Boston Scientific
BSX
$1.96 (-2.17%)
1D
1W
3M
1Y
5Y
ALL
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 3 hours ago • BSX
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN
Zacks Investment Research • 7 hours ago • BSX
Down 6.3% in 4 Weeks, Here's Why Boston Scientific (BSX) Looks Ripe for a Turnaround
Forbes • 7 hours ago • BSX
How Low Can Boston Scientific Stock Go When Markets Turn Sour?
Seeking Alpha • 1 day ago • BSX
Boston Scientific Corporation (BSX) M&A Call Transcript
Proactive Investors • 1 day ago • BSX
Boston Scientific to acquire Penumbra in $14.5B deal
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.